Stay updated on Intranasal Esketamine in Treatment-resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page.

Latest updates to the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page
- Check6 days agoChange DetectedThe footer identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check12 days agoChange DetectedA site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” It is unrelated to the study’s record details.SummaryDifference0.5%

- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2; the study record content is otherwise unchanged.SummaryDifference0.1%

- Check26 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a new revision entry v3.7.0 to the study history, signaling an update to the record. The previous revision v3.6.6 was removed from the history list.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry v3.6.6 has been added to the study record history. The previous revision v3.6.5 is removed from the current history listing.SummaryDifference0.1%

Stay in the know with updates to Intranasal Esketamine in Treatment-resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page.